Paul Kaye is Professor of Immunology and was founding Director of the Centre for Immunology and Infection. Paul has worked for >30 years on the neglected disease leishmaniasis, and is internationally recognized for his research on macrophages and dendritic cells, lymphoid tissue remodelling and granulomatous inflammation. Paul is a Wellcome Senior Investigator and an elected Fellow of the UK Academy of Medical Sciences. He received FRCPath by publication in 2004. Paul’s research tackles leishmaniasis from a holistic viewpoint, rooted in immunology but employing tools and approaches taken from many disciplines, including mathematics, ecology, vector biology and neuroscience. He has extensive links with disease endemic countries and is currently leading a Phase II therapeutic vaccine trial in Sudan and developing a digital pathology platform to facilitate data sharing and collaboration across geographic borders. Paul teaches immunology, infection and pathology in Phase 1.
For details of Professor Kaye’s research, please click here